US authorities are examining the Hepatitis B vaccine for newborns

Health experts appointed by the Trump-era Health Secretary Robert F. Kennedy Jr., known for his vaccine skepticism, are set to evaluate the administration of hepatitis B vaccines to newborns this Thursday. The review may consider postponing the shots despite widespread opposition from medical professionals.

The newly formed Advisory Committee on Immunization Practices (ACIP) will meet for two days in Atlanta, Georgia, following up on recommendations made in September regarding Covid-19 and measles vaccinations. Under Kennedy's leadership, ACIP has launched a broad safety review of multiple long-established vaccines, raising concern within the medical and scientific community.

Medical specialists warn that changes in vaccination policies could lead to declining immunization rates and the resurgence of dangerous diseases such as measles, which claimed lives in 2025. Infectious disease and pediatric expert Sean O'Leary criticized the committee, stating that any modifications would likely be driven by ideology rather than scientific evidence.

Since 1991, US guidelines have recommended hepatitis B vaccination for newborns, as the infection can cause chronic liver disease, cirrhosis, or liver cancer. O'Leary emphasized the stakes: "Ninety percent of babies infected with hepatitis B develop chronic liver disease, and a quarter of them may die from the infection. These deaths are preventable."

Opposition to the vaccine has come from anti-vaccine groups and former President Donald Trump, who suggested in September that children should not receive the hepatitis B vaccine until age 12, arguing that the disease is sexually transmitted. Health professionals counter that newborns can contract the virus from their mothers during pregnancy or childbirth, and delaying vaccination could reduce overall coverage due to inconsistent healthcare access.

Recent research from the University of Minnesota analyzed over 400 studies and found no benefit to postponing the hepatitis B vaccine, highlighting significant risks if current US guidelines were altered.

The ACIP's recommendations have significant implications, as federal vaccine guidelines influence insurance coverage for vaccines in the United States, where medical costs for childbirth and vaccinations can be substantial. However, the committees authority is increasingly challenged, with several Democratic-led states forming independent advisory panels in response to skepticism about Kennedys leadership.

Pediatrician Paul Offit commented on the situation: "States are creating their own advisory committees because they don't trust anything under Robert F. Kennedy Jr., who is an anti-vaccine activist and science denialist. People following ACIP meetings brace themselves for potentially harmful recommendations."

Analysis: Potential Shift in Vaccination Policy Could Have Far-Reaching Consequences

The ongoing review of the hepatitis B vaccination policy by the newly established Advisory Committee on Immunization Practices (ACIP) under Robert F. Kennedy Jr.'s leadership marks a significant point of contention in the ongoing vaccine debate. The committee’s evaluation of delaying the hepatitis B vaccine for newborns has raised concerns not only among healthcare professionals but also within the broader public health community.

While the administration of vaccines to infants has been standard practice in the U.S. since 1991, the current review challenges long-established guidelines. The hepatitis B vaccine, crucial in preventing chronic liver disease and liver cancer, is especially important for infants as they are at a heightened risk of contracting the virus during childbirth. Delaying vaccination, as suggested by some political figures, could lead to significant gaps in immunization rates, which may cause outbreaks of diseases like measles that have already claimed lives in recent years.

Public health experts argue that the ACIP’s decision could set a dangerous precedent. Pediatrician Sean O'Leary’s comments underscore the dire consequences of altering vaccination schedules based on non-scientific reasoning. The emerging skepticism toward ACIP’s leadership only highlights the growing divide between science-backed public health measures and politically motivated policies. The introduction of independent advisory panels by Democratic-led states further illustrates the erosion of trust in the committee’s ability to make impartial decisions.

As the ACIP meets this week to review these crucial vaccination guidelines, it is imperative that the committee’s recommendations are grounded in sound scientific evidence. The potential consequences of undermining the efficacy of vaccination programs are too great to be driven by ideological agendas rather than public health data.

Sources:

• Hepatitis B vaccine for newborns faces scrutiny in US

Author: Olivia Parker
Olivia Parker is a journalist and editor with over 8 years in media. She focuses on culture, arts, and social issues, skilled in feature writing and critical reviews.